A pipeline of novel therapeutic potential for patients

Cell type
Program
Discovery
Preclinical
IND-enabling
Clinical
CAR-NKTCAR-γδ T
Autoimmune
CAR-γδ T
Multiple Myeloma
CAR-NKT
Solid Tumors

Technology that spans the promise of both adaptive and innate immunity by harnessing the potency and universality of invariant T cells

Our Technology
Appia Bio's Technology Lab

If you're passionate about making waves in cell therapy, we'd love to hear from you